FORM OF ORDINARY SHARE PURCHASE WARRANT RELIEF THERAPEUTICS Holding SARelief Therapeutics Holding SA • June 23rd, 2023 • Pharmaceutical preparations • New York
THIS ORDINARY SHARE PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _______________________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after June 22, 2023 (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on June 22, 2028 (the “Termination Date”) but not thereafter, to purchase from RELIEF THERAPEUTICS HOLDING SA, a stock corporation, incorporated under the laws of Switzerland (the “Company”), up to 1,500,000 ordinary shares, par value of CHF 4.00 per share (as subject to adjustment hereunder, the “Warrant Shares”), of the Company. The purchase price of one ordinary share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • June 23rd, 2023 • Relief Therapeutics Holding SA • Pharmaceutical preparations • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of June 15, 2023, between RELIEF THERAPEUTICS Holding SA, a stock corporation, incorporated under the laws of Switzerland (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
